Clinical Trial Update: Acute Effect of Exenatide on Brain Glucose Metabolism [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the acute effect of exenatide on brain glucose metabolism in people with Impaired Glucose Tolerance or diabetes has completed.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Impaired Glucose Tolerance

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Impaired Glucose Tolerance (IGT), Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2017-05-25